CARENE WEINAND: Open Payments
NPI 1407514573 · GILLETTE, WY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$226 in 12 payments from 4 companies in 2025. Trend: 2023 $174 · 2024 $232 · 2025 $226
Food & beverage: $226
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $103 |
| Novo Nordisk Inc | 2 | $51 |
| Lilly USA, LLC | 3 | $50 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
Products named: BREZTRI, FARXIGA, MOUNJARO, Wegovy, LEQVIO, Ozempic, ZEPBOUND.
Industry payments across WY — which companies pay providers there.
